King Pharma Allocates, Breaks

The $200 million term loan backing King Pharmaceuticals' acquisition of Alpharma allocated and broke for trading Dec. 19.

  • 24 Dec 2008
The $200 million term loan backing King Pharmaceuticals' acquisition of Alpharma allocated and broke for trading Dec. 19. Lead bank Credit Suisse did not put out any levels as it was mainly marketed to banks during syndication. "It's held mostly by banks, so I don't imagine it will ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Share % by Volume
1 Societe Generale 13.43
2 Rabobank 12.61
3 Morgan Stanley 10.27
4 Barclays 7.86
5 Natwest Markets (RBS) 7.15

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 27 Mar 2017
1 Bank of America Merrill Lynch 18,561.02 56 11.69%
2 Wells Fargo Securities 18,160.90 57 11.44%
3 JPMorgan 12,092.45 38 7.62%
4 Citi 11,878.92 43 7.48%
5 Credit Suisse 9,276.87 26 5.84%